Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
about
Pathogen-reduced platelets for the prevention of bleedingPathogen-reduced platelets for the prevention of bleedingIrradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivoPathogen inactivation technologies for cellular blood components: an updateA pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung Injury.Component pathogen inactivation: a critical review.In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusionMalaria Parasitaemia among Blood Donors in Ilorin, NigeriaUVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.PACK-CXL: Corneal Cross-linking for Treatment of Infectious KeratitisTreatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood StorageDeficiency in frataxin homologue YFH1 in the yeast Pichia guilliermondii leads to missregulation of iron acquisition and riboflavin biosynthesis and affects sulfate assimilation.Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.Update on the use of pathogen-reduced human plasma and platelet concentrates.Riboflavin interactions with oxygen-a survey from the photochemical perspective.Modern banking, collection, compatibility testing and storage of blood and blood components.Pathogen-reduced platelets for the prevention of bleeding.Antitumor activity of irradiated riboflavin on human renal carcinoma cell line 786-O.Evaluation of the in vitro antimicrobial properties of ultraviolet A/riboflavin mediated crosslinking on Candida albicans and Fusarium solani.Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.Tryptophan oxidation catabolite, N-formylkynurenine, in photo degraded cell culture medium results in reduced cell culture performance.The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light.Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion.Development of a riboflavin and ultraviolet light-based device to treat whole blood.Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?Collagen Cross-Linking in the Management of Microbial Keratitis.Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage.Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study.Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
P2860
Q24199041-24472E3D-0F88-49A2-BE62-E508BEC935B4Q24235318-E7AE14C7-8D51-4447-87F3-0571C8CE0FA3Q28485143-C27DE016-81C8-47D7-9518-98BF2BE625B2Q28655769-9F9128E9-76BB-4BB2-A2C4-D3BDCEFD1F91Q33405052-A38B9B62-EEEE-498E-95B2-E052CBD53D85Q33841435-58690DCC-552D-4832-BC61-1848C32EE597Q33852543-57A41DB4-3CC5-45E5-9941-3BE099160938Q33863382-C3D2D9FB-4139-469C-AE1B-23724BE7B033Q34310415-97EEFDBD-24C2-4D4F-9D7E-95A361962F12Q35041519-54836A3D-4423-48CD-BFB5-81930C392E95Q35075696-597A347B-F04E-40E2-9142-EB1D7DC044EDQ35095651-E0123456-26FE-45A1-A5A6-EF01E25C8FADQ35640516-444D5DB5-4D5E-442E-BC52-F698C5D8C3ECQ35841288-5F6272E3-802D-4916-BFDE-7E9292CD733EQ36190450-BEC2E94D-D055-493D-BB33-20C50D309638Q36408117-69FCE098-11B1-4757-8F1F-99C9B8F8A675Q37903671-2D6A3F59-A1C8-459F-B603-F7EFC469DEB2Q38109665-2DF648C1-CFA0-41F6-A723-D39DC7FFBED1Q38258793-3669DA09-9E9E-479C-9458-5E60985915DCQ38273780-C9C89C17-5C4F-40F6-8A3F-E08CC5050181Q38653240-105BE254-75B8-45E9-AB98-838DEFAA0873Q38951552-3B5C36D6-23B7-4F8C-B5BC-00DD630D1D8FQ39023767-0F6152D2-68AD-4C81-9059-D28B49010008Q40099637-84F96A7B-CD1F-41EF-8682-EC7A7D8370BDQ40330035-C8D75A65-FBD4-4516-AD5F-7C9DFDA27A6DQ41606941-BAAD0596-1EA3-439F-83F9-B23FDD26B6F2Q41640997-5B1F824D-C304-4B9F-83F2-AB720C713354Q41897296-E5B1F99F-61DB-4806-86FA-4C47C29F4AE8Q42015397-151A4122-6D4F-492B-A1BF-2DCF3DAF3552Q42278634-50C7D3AB-E977-41B3-851B-55CF700DD397Q42807082-5EC0308C-3194-4086-8CAA-B89E2B79DAF7Q44120840-9033B3E2-6CFE-4739-BC01-37D909A28465Q46505820-46FD251F-D759-46CF-97B8-4675C2428049Q47198948-E4A76F9B-3985-448E-8EC3-E2E9E027EA1AQ49958847-92DFEE7F-81F5-448B-A8CE-3ABD3AD6DC63Q53123053-0C93D268-8601-4F37-B4A2-F8D3C7534871Q53251240-0C35C6EE-E1DB-4400-B288-4D309B88805F
P2860
Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Toxicity testing of a novel ri ...... white blood cell inactivation.
@ast
Toxicity testing of a novel ri ...... white blood cell inactivation.
@en
Toxicity testing of a novel ri ...... white blood cell inactivation.
@nl
type
label
Toxicity testing of a novel ri ...... white blood cell inactivation.
@ast
Toxicity testing of a novel ri ...... white blood cell inactivation.
@en
Toxicity testing of a novel ri ...... white blood cell inactivation.
@nl
prefLabel
Toxicity testing of a novel ri ...... white blood cell inactivation.
@ast
Toxicity testing of a novel ri ...... white blood cell inactivation.
@en
Toxicity testing of a novel ri ...... white blood cell inactivation.
@nl
P2093
P1476
Toxicity testing of a novel ri ...... white blood cell inactivation
@en
P2093
Anthony D Dayan
Heather L Reddy
Joy Cavagnaro
Shayne Gad
P304
P356
10.1016/J.TMRV.2007.12.003
P577
2008-04-01T00:00:00Z